title: Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction.
abstract: Elevated levels of collagen as well as transient increases of glycosaminoglycans (GAG) have been shown in the myocardium remote to the infarction. The aim of the study is to observe the effect of melatonin on the accumulation of collagen and GAG in the left ventricle wall, remote to the infarction. A second aim is to determine whether the effect of the pineal indole is mediated by the membrane melatonin receptors of heart fibroblasts. Rats with myocardial infarction induced by ligation of the left coronary artery were treated with melatonin at a dose of 60 μg/100 g b.w. or vehicle (2% ethanol in 0.9% NaCl). The results were compared with an untreated control. In the second part of the study, the fibroblasts from the non-infarcted part of myocardium were isolated and cultured. Melatonin at a range of concentrations from 10(-8) M to 10(-6) M was applied to the fibroblast cultures. In the final part of the study, the influence of luzindole (10(-6) M), the melatonin membrane receptor inhibitor, on melatonin-induced GAG augmentation was investigated. Both collagen and GAG content were measured in the experiment. Melatonin elevated GAG content in the myocardium remote to the infarcted heart. Collagen level was not changed by pineal indoleamine. Fibroblasts isolated from the myocardium varied in shape from fusiform to spindle-shaped. Moreover, the pineal hormone (10(-7)M and 10(-6)M) increased GAG accumulation in the fibroblast culture. Luzindole inhibited melatonin-induced elevation of GAG content at 10(-6)M. Melatonin increased GAG content in the myocardium remote to infarction. This effect was dependent on the direct influence of the pineal indole on the heart fibroblasts. The melatonin-induced GAG elevation is blocked by luzindole, the melatonin membrane receptors inhibitor, indicating a direct effect of this indole.
authors.affiliation: Laboratory of Connective Tissue Metabolism, Medical University of Lodz, Lodz, Poland. drob@op.pl.
authors.forename: J
authors.initials: J
authors.lastname: Drobnik
authors.forename: D
authors.initials: D
authors.lastname: Tosik
authors.forename: L
authors.initials: L
authors.lastname: Piera
authors.forename: A
authors.initials: A
authors.lastname: Szczepanowska
authors.forename: S
authors.initials: S
authors.lastname: Olczak
authors.forename: A
authors.initials: A
authors.lastname: Zielinska
authors.forename: P P
authors.initials: PP
authors.lastname: Liberski
authors.forename: J
authors.initials: J
authors.lastname: Ciosek
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism*; D006352:Heart Ventricles / Q000166:cytology / Q000378:metabolism; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D009203:Myocardial Infarction / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D044094:Receptors, Melatonin / Q000037:antagonists & inhibitors; D014363:Tryptamines / Q000494:pharmacology
chemical_list: D006025:Glycosaminoglycans; D044094:Receptors, Melatonin; D014363:Tryptamines; C057154:luzindole; D003094:Collagen; D008550:Melatonin